CRNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,786,054.74

Crinetics Pharmaceuticals Insider Trading History Chart

Crinetics Pharmaceuticals Share Price & Price History

^$35.40

▲ +1.14 (3.33%)

As of 03/12/2025 05:00 PM ET

Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/3/2025	Dana Pizzuti	Insider	Sell	5,000	$39.07	$195,350.00	31,748
11/22/2024	Jeff E. Knight	COO	Sell	501	$56.52	$28,316.52	51,653
10/3/2024	Dana Pizzuti	Insider	Sell	14,375	$54.63	$785,306.25	28,507
9/26/2024	Marc Wilson	CFO	Sell	25,000	$51.11	$1,277,750.00	111,092
9/10/2024	Stephen F. Betz	Insider	Sell	1,035	$51.50	$53,302.50	68,576
8/26/2024	Stephen F. Betz	Insider	Sell	3,000	$53.19	$159,570.00	69,611
7/25/2024	Marc Wilson	CFO	Sell	19,056	$53.88	$1,026,737.28	111,092
7/25/2024	Stephen F. Betz	Insider	Sell	3,000	$53.43	$160,290.00	75,611
7/15/2024	Jeff E. Knight	COO	Sell	27,000	$55.00	$1,485,000.00	51,653
7/15/2024	Marc Wilson	CFO	Sell	25,000	$55.00	$1,375,000.00	111,092
7/10/2024	Stephen F. Betz	Insider	Sell	3,000	$48.55	$145,650.00	78,611
7/5/2024	James Hassard	Insider	Sell	15,000	$44.08	$661,200.00	29,259
7/3/2024	Dana Pizzuti	Insider	Sell	14,375	$44.87	$645,006.25	28,507
6/28/2024	Marc Wilson	CFO	Sell	32,129	$43.61	$1,401,145.69	111,092
6/26/2024	Jeff E. Knight	COO	Sell	956	$44.38	$42,427.28	52,580
6/24/2024	Dana Pizzuti	Insider	Sell	9,500	$45.73	$434,435.00	27,786
6/21/2024	James Hassard	Insider	Sell	15,000	$44.66	$669,900.00	29,259
6/10/2024	Stephen F. Betz	Insider	Sell	3,000	$43.86	$131,580.00	83,643
5/28/2024	Stephen F. Betz	Insider	Sell	3,000	$47.49	$142,470.00	86,643
5/10/2024	Stephen F. Betz	Insider	Sell	3,000	$49.43	$148,290.00	89,643
5/8/2024	Richard Scott Struthers	CEO	Sell	107,448	$49.40	$5,307,931.20	257,485
4/15/2024	Dana Pizzuti	Insider	Sell	14,375	$44.47	$639,256.25	27,786
4/4/2024	Richard Scott Struthers	CEO	Sell	40,951	$49.17	$2,013,560.67	237,835
3/28/2024	Stephanie Okey	Director	Sell	17,500	$46.38	$811,650.00	6,000
3/22/2024	Jeff E. Knight	COO	Sell	32,359	$44.31	$1,433,827.29	52,580
3/20/2024	Dana Pizzuti	Insider	Sell	15,089	$44.06	$664,821.34	27,786
3/20/2024	Matthew K. Fust	Director	Sell	60,000	$44.14	$2,648,400.00	18,536
3/19/2024	Marc Wilson	CFO	Sell	6,942	$42.91	$297,881.22	110,630
1/25/2024	Stephen F. Betz	Insider	Sell	3,000	$37.26	$111,780.00	73,298
1/10/2024	Stephen F. Betz	Insider	Sell	3,000	$37.65	$112,950.00	76,298
1/3/2024	Dana Pizzuti	Insider	Sell	14,375	$35.00	$503,125.00	5,911
1/2/2024	Marc Wilson	CFO	Sell	10,000	$35.47	$354,700.00	96,055
12/26/2023	Stephen F. Betz	Insider	Sell	3,000	$35.89	$107,670.00	79,298
12/21/2023	Dana Pizzuti	Insider	Sell	9,583	$34.57	$331,284.31	5,911
12/11/2023	Stephen F. Betz	Insider	Sell	3,000	$32.87	$98,610.00	82,298
11/27/2023	Stephen F. Betz	Insider	Sell	3,000	$31.84	$95,520.00	85,298
11/3/2023	Richard Scott Struthers	CEO	Sell	199,082	$30.56	$6,083,945.92	135,522
11/1/2023	Marc Wilson	CFO	Sell	10,000	$28.75	$287,500.00	95,601
10/17/2023	Alan Seth Krasner	Insider	Sell	7,000	$30.00	$210,000.00	43,210
7/13/2023	Richard Scott Struthers	CEO	Sell	14,157	$20.35	$288,094.95	630,805
7/11/2023	Richard Scott Struthers	CEO	Sell	24,384	$20.14	$491,093.76	656,421
6/20/2023	Marc Wilson	CFO	Sell	30,922	$19.97	$617,512.34	95,158
6/16/2023	Richard Scott Struthers	CEO	Sell	50,000	$20.81	$1,040,500.00	680,805
6/8/2023	Coelho Rogerio Vivaldi	Director	Buy	5,000	$22.06	$110,300.00	5,000
4/5/2023	Dana Pizzuti	Insider	Sell	8,212	$16.15	$132,623.80	4,500
1/25/2023	Stephen F. Betz	Insider	Sell	8,336	$21.07	$175,639.52	67,815
1/17/2023	Stephen F. Betz	Insider	Sell	3,126	$18.00	$56,268.00	76,151
12/15/2022	Stephen F. Betz	Insider	Sell	3,126	$16.00	$50,016.00	82,403
12/1/2022	Stephen F. Betz	Insider	Sell	3,126	$17.84	$55,767.84	84,968
11/15/2022	Stephen F. Betz	Insider	Sell	3,126	$18.72	$58,518.72	88,094
10/17/2022	Stephen F. Betz	Insider	Sell	3,126	$17.73	$55,423.98	94,346
10/3/2022	Stephen F. Betz	Insider	Sell	3,126	$19.64	$61,394.64	97,472
9/15/2022	Stephen F. Betz	Insider	Sell	4,168	$21.01	$87,569.68	100,598
9/7/2022	Stephen F. Betz	Insider	Sell	1,042	$21.00	$21,882.00	104,766
7/26/2022	Jeff E. Knight	COO	Sell	1,152	$20.70	$23,846.40	4,950
7/13/2022	Matthew K. Fust	Director	Sell	5,700	$20.96	$119,472.00	12,536
5/2/2022	Stephen F. Betz	Insider	Sell	3,247	$20.10	$65,264.70	107,598
4/18/2022	Perceptive Advisors Llc	Major Shareholder	Buy	157,515	$22.22	$3,499,983.30	5,321,032
4/18/2022	Stephen F. Betz	Insider	Sell	5,664	$25.81	$146,187.84	110,845
4/13/2022	Richard Scott Struthers	CEO	Sell	138,643	$26.83	$3,719,791.69	730,805
4/5/2022	Richard Scott Struthers	CEO	Sell	21,357	$25.34	$541,186.38	57,400
4/4/2022	Stephen F. Betz	Insider	Sell	9,000	$23.97	$215,730.00	116,509
3/31/2022	Stephen F. Betz	Insider	Sell	4,164	$21.06	$87,693.84

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

98.51% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	334,783	$17.12M	0.0%	N/A	0.361%
2/20/2025	Mackenzie Financial Corp	5,422	$0.28M	0.0%	+8.8%	0.006%
2/19/2025	GF Fund Management CO. LTD.	1,947	$100K	0.0%	N/A	0.002%
2/18/2025	Castleark Management LLC	77,780	$3.98M	0.1%	+6.1%	0.084%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	325,276	$16.63M	0.0%	+19.7%	0.351%
2/17/2025	Woodline Partners LP	50,000	$2.56M	0.0%	N/A	0.054%
2/17/2025	Soleus Capital Management L.P.	85,000	$4.35M	0.3%	N/A	0.092%
2/17/2025	Two Sigma Advisers LP	8,100	$0.41M	0.0%	-63.8%	0.009%
2/17/2025	State of Wyoming	985	$50K	0.0%	N/A	0.001%
2/17/2025	Tema Etfs LLC	57,933	$2.96M	1.2%	N/A	0.062%
2/17/2025	Stempoint Capital LP	317,060	$16.21M	4.0%	+48.3%	0.342%
2/17/2025	Rafferty Asset Management LLC	81,257	$4.16M	0.0%	-16.6%	0.088%
2/17/2025	Point72 Asset Management L.P.	2,788,939	$142.60M	0.3%	+21.2%	3.007%
2/17/2025	ProShare Advisors LLC	29,089	$1.49M	0.0%	+49.7%	0.031%
2/17/2025	MPM Bioimpact LLC	617,035	$31.55M	4.5%	+17.3%	0.665%
2/17/2025	Paradigm Biocapital Advisors LP	1,910,761	$97.70M	3.4%	-24.1%	2.060%
2/17/2025	Parkman Healthcare Partners LLC	51,133	$2.61M	0.3%	-34.1%	0.055%
2/17/2025	Nicholas Investment Partners LP	127,283	$6.51M	0.6%	+35.6%	0.137%
2/17/2025	Nuveen Asset Management LLC	527,792	$26.99M	0.0%	+2.6%	0.569%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	27,687	$1.42M	0.1%	+12.1%	0.030%
2/17/2025	Orbimed Advisors LLC	999,000	$51.08M	1.1%	-4.9%	1.077%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	53,163	$2.72M	0.0%	+14.5%	0.057%
2/17/2025	Janus Henderson Group PLC	2,795,441	$142.90M	0.1%	+15.1%	3.014%
2/17/2025	Ensign Peak Advisors Inc	502,690	$25.70M	0.0%	-18.5%	0.542%
2/17/2025	Farallon Capital Management LLC	4,075,098	$208.36M	1.1%	+250.7%	4.394%
2/17/2025	D. E. Shaw & Co. Inc.	9,876	$0.51M	0.0%	-85.0%	0.011%
2/17/2025	Deutsche Bank AG	211,314	$10.80M	0.0%	-2.2%	0.228%
2/17/2025	Driehaus Capital Management LLC	6,141,014	$313.99M	2.6%	+4.3%	6.622%
2/17/2025	Duquesne Family Office LLC	122,700	$6.27M	0.2%	-60.3%	0.132%
2/17/2025	Cresset Asset Management LLC	7,224	$0.37M	0.0%	-20.4%	0.008%
2/17/2025	Brevan Howard Capital Management LP	9,777	$0.50M	0.0%	N/A	0.011%
2/17/2025	Bank of America Corp DE	235,281	$12.03M	0.0%	-15.4%	0.254%
2/17/2025	BNP Paribas Financial Markets	15,259	$0.78M	0.0%	-27.1%	0.016%
2/17/2025	Ameriprise Financial Inc.	355,174	$18.16M	0.0%	+110.8%	0.383%
2/17/2025	Algert Global LLC	28,777	$1.47M	0.0%	-32.7%	0.031%
2/17/2025	Allostery Investments LP	9,700	$0.50M	0.5%	N/A	0.010%
2/17/2025	Acuta Capital Partners LLC	122,900	$6.28M	6.3%	-6.7%	0.133%
2/14/2025	Novo Holdings A S	960,215	$49.10M	3.0%	-4.0%	1.035%
2/14/2025	Jane Street Group LLC	7,404	$0.38M	0.0%	-94.3%	0.008%
2/14/2025	Schonfeld Strategic Advisors LLC	445,946	$22.80M	0.1%	-9.1%	0.481%
2/14/2025	First Light Asset Management LLC	885,453	$45.27M	4.3%	-6.2%	0.955%
2/14/2025	Northern Trust Corp	879,814	$44.99M	0.0%	+20.4%	0.949%
2/14/2025	The Manufacturers Life Insurance Company	148,956	$7.62M	0.0%	+11.1%	0.161%
2/14/2025	Decheng Capital LLC	167,958	$8.59M	1.8%	+6.3%	0.181%
2/14/2025	Aquatic Capital Management LLC	27,712	$1.42M	0.0%	N/A	0.030%
2/14/2025	Boothbay Fund Management LLC	137,752	$7.04M	0.2%	+25.9%	0.149%
2/14/2025	Virtus ETF Advisers LLC	1,279	$65K	0.0%	-34.8%	0.001%
2/14/2025	Gilder Gagnon Howe & Co. LLC	25,044	$1.28M	0.0%	+98.5%	0.027%
2/14/2025	Lord Abbett & CO. LLC	724,625	$37.05M	0.1%	-2.9%	0.781%
2/14/2025	Voya Investment Management LLC	389,220	$19.90M	0.0%	+0.1%	0.420%
2/14/2025	Adage Capital Partners GP L.L.C.	65,000	$3.32M	0.0%	+62.5%	0.070%
2/14/2025	Hood River Capital Management LLC	851,400	$43.53M	0.6%	+2.0%	0.918%
2/14/2025	T. Rowe Price Investment Management Inc.	1,002,882	$51.28M	0.0%	-6.1%	1.081%
2/14/2025	Price T Rowe Associates Inc. MD	5,414,505	$276.84M	0.0%	+9.5%	5.838%
2/14/2025	Diadema Partners LP	25,900	$1.32M	0.6%	N/A	0.028%
2/14/2025	Hsbc Holdings PLC	12,552	$0.65M	0.0%	+61.7%	0.014%
2/14/2025	Rock Springs Capital Management LP	294,100	$15.04M	0.6%	+1.6%	0.317%
2/14/2025	Tower Research Capital LLC TRC	7,412	$0.38M	0.0%	+1,539.8%	0.008%
2/14/2025	MetLife Investment Management LLC	53,020	$2.71M	0.0%	+18.0%	0.057%
2/14/2025	First Trust Advisors LP	195,821	$10.01M	0.0%	-6.9%	0.211%
2/13/2025	CANADA LIFE ASSURANCE Co	19,219	$0.98M	0.0%	+10.8%	0.021%
2/13/2025	PEAK6 LLC	10,000	$0.51M	0.0%	N/A	0.011%
2/13/2025	Affinity Asset Advisors LLC	460,000	$23.52M	3.1%	+15.0%	0.496%
2/13/2025	Guggenheim Capital LLC	26,143	$1.34M	0.0%	-7.2%	0.028%
2/13/2025	Barclays PLC	181,941	$9.30M	0.0%	-12.4%	0.196%
2/13/2025	Summit Investment Advisors Inc.	9,174	$0.47M	0.4%	+16.4%	0.010%
2/13/2025	Martingale Asset Management L P	22,484	$1.15M	0.0%	+1.9%	0.024%
2/13/2025	Legal & General Group Plc	88,939	$4.55M	0.0%	+16.4%	0.096%
2/13/2025	Invesco Ltd.	298,254	$15.25M	0.0%	+16.8%	0.322%
2/13/2025	ADAR1 Capital Management LLC	53,125	$2.72M	0.5%	-39.9%	0.057%
2/13/2025	FMR LLC	8,928,086	$456.49M	0.0%	+100.4%	9.627%
2/13/2025	Russell Investments Group Ltd.	34,200	$1.75M	0.0%	-56.0%	0.037%
2/13/2025	Envestnet Asset Management Inc.	63,077	$3.23M	0.0%	+16.1%	0.068%
2/13/2025	Wells Fargo & Company MN	100,916	$5.16M	0.0%	+18.9%	0.109%
2/12/2025	Cinctive Capital Management LP	36,988	$1.89M	0.1%	-25.2%	0.040%
2/12/2025	Bryce Point Capital LLC	22,686	$1.16M	0.3%	N/A	0.024%
2/12/2025	Headlands Technologies LLC	1,022	$52K	0.0%	N/A	0.001%
2/12/2025	Geode Capital Management LLC	2,098,841	$107.34M	0.0%	+13.6%	2.263%
2/12/2025	Franklin Resources Inc.	1,591,666	$81.38M	0.0%	+14.5%	1.716%
2/12/2025	Alliancebernstein L.P.	101,720	$5.20M	0.0%	+9.9%	0.110%
2/12/2025	Wellington Management Group LLP	6,950,567	$355.38M	0.1%	+55.9%	7.495%
2/12/2025	Schroder Investment Management Group	29,361	$1.49M	0.0%	N/A	0.032%
2/12/2025	Orion Portfolio Solutions LLC	16,721	$0.86M	0.0%	-8.3%	0.018%
2/12/2025	Pictet Asset Management Holding SA	848,050	$43.36M	0.0%	-6.6%	0.914%
2/12/2025	NEOS Investment Management LLC	57,933	$2.96M	0.1%	+0.9%	0.062%
2/12/2025	JPMorgan Chase & Co.	269,543	$13.78M	0.0%	-5.7%	0.291%
2/11/2025	Pier Capital LLC	111,999	$5.73M	0.8%	+3.4%	0.121%
2/11/2025	Segall Bryant & Hamill LLC	150,398	$7.69M	0.1%	N/A	0.162%
2/11/2025	Prudential Financial Inc.	277,370	$14.18M	0.0%	+60.5%	0.299%
2/11/2025	Corebridge Financial Inc.	43,599	$2.23M	0.0%	+4.8%	0.047%
2/11/2025	Vanguard Group Inc.	9,089,391	$464.74M	0.0%	+44.6%	9.801%
2/11/2025	LPL Financial LLC	6,071	$0.31M	0.0%	+23.7%	0.007%
2/11/2025	KLP Kapitalforvaltning AS	16,000	$0.82M	0.0%	N/A	0.017%
2/11/2025	Sei Investments Co.	55,727	$2.85M	0.0%	-0.8%	0.060%
2/11/2025	American Century Companies Inc.	477,298	$24.40M	0.0%	+23.4%	0.515%
2/11/2025	Teacher Retirement System of Texas	24,003	$1.23M	0.0%	+42.8%	0.026%
2/11/2025	Harvest Fund Management Co. Ltd	1,299	$66K	0.0%	N/A	0.001%
2/11/2025	Xponance Inc.	6,284	$0.32M	0.0%	+22.8%	0.007%
2/11/2025	Intech Investment Management LLC	43,105	$2.20M	0.1%	+92.9%	0.046%
2/10/2025	Cibc World Markets Corp	8,206	$0.42M	0.0%	N/A	0.009%

Data available starting January 2016

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Today's Range

Now: $35.40

$34.46

$35.54

50 Day Range

MA: $38.53

$32.30

$53.15

52 Week Range

Now: $35.40

$31.84

$62.53

Volume

652,764 shs

Average Volume

1,021,082 shs

Market Capitalization

$3.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top insider investors include:
Richard Scott Struthers (CEO)
Marc Wilson (CFO)
Stephen F Betz (Insider)
Jeff E Knight (COO)
Alan Seth Krasner (Insider)
Dana Pizzuti (Insider)
James Hassard (Insider)
Matthew K Fust (Director)
Stephanie Okey (Director)
Coelho Rogerio Vivaldi (Director)
Learn More about top insider investors at Crinetics Pharmaceuticals.
Who are the major institutional investors of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.80%
FMR LLC — 9.63%
Wellington Management Group LLP — 7.49%
Driehaus Capital Management LLC — 6.62%
Price T Rowe Associates Inc. MD — 5.84%
Farallon Capital Management LLC — 4.39%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.
Which institutional investors are selling Crinetics Pharmaceuticals stock?: During the previous quarter, CRNX stock was sold by these institutional investors:
Paradigm Biocapital Advisors LP
Duquesne Family Office LLC
Jane Street Group LLC
Ensign Peak Advisors Inc
Jennison Associates LLC
T. Rowe Price Investment Management Inc.
Victory Capital Management Inc.
Pictet Asset Management Holding SA
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
Richard Scott Struthers (CEO)
Marc Wilson (CFO)
Stephen F Betz (Insider)
Jeff E Knight (COO)
Alan Seth Krasner (Insider)
Dana Pizzuti (Insider)
James Hassard (Insider)
Matthew K Fust (Director)
Learn More investors selling Crinetics Pharmaceuticals stock.
Which institutional investors are buying Crinetics Pharmaceuticals stock?: In the last quarter, CRNX stock was bought by institutional investors including:
FMR LLC
Farallon Capital Management LLC
Vanguard Group Inc.
Wellington Management Group LLP
SG Americas Securities LLC
Point72 Asset Management L.P.
Price T Rowe Associates Inc. MD
Janus Henderson Group PLC